Related Experiment Videos
Hemostasis in massively transfused trauma patients
Annals of Surgery
|July 1, 1979
Summary
Massive transfusions can cause bleeding disorders due to low platelet counts (thrombocytopenia). Platelet concentrates effectively control bleeding in most patients, negating the need for fresh blood products.
Area of Science:
- Transfusion Medicine
- Hematology
- Critical Care Medicine
Background:
- Massive transfusions are critical in managing severe hemorrhage.
- Stored, modified whole blood is commonly used, but its impact on hemostasis requires clarification.
Purpose of the Study:
- To investigate if stored whole blood transfusions cause hemostatic disorders.
- To identify predictors of abnormal bleeding during massive transfusions.
Main Methods:
- Prospective study of 27 patients receiving massive transfusions.
- Monitoring of platelet counts and coagulation factors.
- Correlation of laboratory values with transfusion volume and bleeding events.
Main Results:
- Platelet counts decreased proportionally with blood units transfused.
- Abnormal bleeding occurred in 8 patients, primarily due to dilutional thrombocytopenia or DIC.
- Platelet concentrates controlled bleeding in most cases; fibrinogen levels aided DIC diagnosis.
Conclusions:
- Dilutional thrombocytopenia is a primary cause of bleeding after massive transfusions.
- Platelet counts are the most reliable predictor of bleeding risk.
- Platelet concentrates are recommended for managing bleeding; fresh blood products are generally unnecessary.